Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Roscovitine MeSH Descriptor Data 2026


MeSH Heading
Roscovitine
Tree Number(s)
D03.633.100.759.776
Unique ID
D000077546
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077546
Scope Note
A purine derivative and competitive inhibitor of CYCLIN-DEPENDENT KINASES that has therapeutic potential as an antineoplastic and antiviral agent.
Entry Term(s)
(2R)-2-((6-Benzylamino-9-(propan-2-yl)-9H-purin-2-yl)amino)butan-1-ol
2-(1-Ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine
CYC 202
CYC-202
CYC202
R-roscovitine
Seliciclib
Pharm Action
Antineoplastic Agents
Antiviral Agents
Protein Kinase Inhibitors
Registry Numbers
0ES1C2KQ94
0
Public MeSH Note
2019; ROSCOVITINE was indexed under PURINES 1997-2018
History Note
2019 (1997)
Date Introduced
2019/01/01
Last Updated
2019/01/01
Roscovitine Preferred
CYC 202 Narrower
R-roscovitine Narrower
Seliciclib Narrower
2-(1-Ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine Related
page delivered in 0.165s